Loads of them. Evidence variable. As long as they are cheaper than VSL#3 and they have evidence for them it’s a buyers choice but we still don’t know enough to make stronger recommendations except in certain circumstances.
Month: June 2016
New GOJ stents
This is a new stent for the GOJ. Can be used in both benign and malignant disease. But is it just like all the others which migrate?
This one is designed for variceal bleeds as a second line therapy instead of sengstaken. Of the two I think this one is more interesting.
Is this an alternative future for IBD treatment?
Data from the ART trial interesting associated set up costs similar to infliximab. This could be useful in patients with refractory IBD
Nasal bridles help save lives
This is my poster for the BSG2016. It’s not quit as straightforward as I’m making out but we did find that bridles helped in our elderly cohort. 
Goodbye to Ian Forgacs
Bye Ian. You’ve done a great job
More therapies for IBD
Just saw a talk on Ustekinumab by Prof Ghosh. Looks like it might well be yet another weapon in the arsenal to treat treatment resistant Crohn’s.
The clip to eat all others?
http://www.ovesco. Mega Clip – interesting. At BSG 2016 seems to be useful for removing large lesions and stopping large bleeds but it’s so beastly you might bite off more than you bargained for
It begins
Right, it’s time for me to start sharing things online. Endoscopy, gastroenterology, Healthcare innovation and improving patient care are my things and it’s time to start blogging about them.
Matt Stammers' Blog 
You must be logged in to post a comment.